Potential role of statin use in idiopathic pulmonary fibrosis

American Journal of Respiratory and Critical Care Medicine

Volumn 177, Issue 9, 2008, Pages 1048-

  Santana, Alfredo N C ^a   Kairalla, Ronaldo A ^a   Carvalho, Carlos R R ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANTICOAGULANT AGENT; BOSENTAN; CONNECTIVE TISSUE GROWTH FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SILDENAFIL;

ATHEROSCLEROSIS; DOWN REGULATION; DRUG EFFECT; ENDOTHELIUM CELL; FIBROSING ALVEOLITIS; GERIATRIC PATIENT; HUMAN; LETTER; LUNG FUNCTION; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; SURVIVAL; LUNG FIBROSIS; METABOLISM; NOTE; TREATMENT OUTCOME;

HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PULMONARY FIBROSIS; TREATMENT OUTCOME;

EID: 42949145940     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/ajrccm.177.9.1048     Document Type: Letter

References (6)